Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer’s disease

By Ott Brian   Blake Lesley   Kagan Ethel   Resnick Malca  

Journal of Neurology, Vol. 254, Iss. 3, 2007-03 ,pp. : 351-358

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Somatization Disorder with Nefazodone: A Prospective, Open-Label Study

By Menza M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 3, 2001-09 ,pp. : 153-158

Springer Publishing Company

Access to resources Recommend Favorite

Olanzapine in the treatment of depression with psychotic features: A prospective open-label study

By Adli Mazda   Wiethoff Katja   Baethge Christopher   Pfennig Andrea   Stamm Thomas   Bauer Michael  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 202-209

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Open-Label Dosage and Tolerability Study of Tiagabine Monotherapy in Patients with Refractory Complex Partial Seizures

By Schachter S.C.   Cahill W.T.   Wannamaker B.B.   Shu V.S.   Sommerville K.W.  

Journal of Epilepsy, Vol. 11, Iss. 5, 1998-09 ,pp. : 248-255

Elsevier

Access to resources Recommend Favorite

Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study

By Braunig Peter   Sacchetti Emilio   Medori Rossella  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 1, 2008-01 ,pp. : 74-77

Ashgate Publishing Ltd

Access to resources Recommend Favorite